80
59
Growth Score
-11 pts
Heat Score
-28 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
784976
Neurophoenix is a biopharmaceutical company developing a new therapeutic solution for optic neuropathies.
About the Company
Neurophoenix is a biopharmaceutical company developing a new therapeutic solution for optic neuropathies, one of the leading causes of blindness worldwide. The company is building a pipeline of novel first-in-class drugs which combine both neuroprotective and neuroregenerative properties.
This new therapeutic approach is based on the research
conducted at the Institut Pasteur (Paris) by the Viral Neuro-Immunology team, led by Dr. Monique Lafon.
Neurophoenix was created in August 2018. The company was a laureate and “Grand Prize” of the 2018 i-Lab Innovation Contest organized by the French Ministry of Research.
